Ucb Unsponsored Adr News, Ucb Unsponsored Adr Quote, UCBJY Quote

Ucb Unsponsored Adr (OP:UCBJY) Delayed: 119.35 +2.28 (1.95%)

Prev. Close

$117.07

Today 6M 1Y 5Y

Open

$121.61

52 Wk High

$46.25

52 Wk Low

$32.74

Day High

$121.61

Day Low

$119.21

P/E

N/A

EPS

$0.00

Volume

59,276

Friends, Peers and Foes (?): UCB:BB, UCB REGN (more...)

ALERTS | RSS

Sep 4, 2026 06:07 AM BofA Securities Reiterates Buy Rating on UCB (UCB:BB) (UCBJY)
Aug 16, 2026 08:05 AM Axios Names UCB a Winner of the Metro Atlanta Top Workplaces 2026 Award
Aug 5, 2026 10:40 AM Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
Aug 4, 2026 05:33 AM UBS Reiterates Buy Rating on UCB (UCB:BB) (UCBJY)
Aug 3, 2026 04:44 AM UCB (UCB:BB) (UCBJY) PT Lowered to EUR260 at Barclays
Aug 3, 2026 01:34 AM Jefferies Upgrades UCB SA (UCB:BB) (UCBJY) to Hold
Jul 8, 2026 09:02 AM UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.
Jul 2, 2026 05:06 AM UCB (UCB:BB) (UCBJY) PT Raised to EUR305 at Berenberg
Jun 22, 2026 08:21 AM UCB (UCB:BB) (UCBJY) PT Lowered to EUR320 at UBS
Jun 17, 2026 07:00 AM UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)

Entities mentioned with UCBJY

View All Entities